CLINICAL TRIALS PROFILE FOR LOTEPREDNOL ETABONATE
All Clinical Trials for loteprednol etabonate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00366691 ↗ | Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation | Completed | Medical University of South Carolina | Phase 4 | 2006-02-01 | The purpose of this study is to compare the effectiveness of Acular LS® and Lotemax® in the prevention of inflammation in the eye after cataract surgery. Acular LS is made by Allergan, Inc. It is a nonsteroidal anti-inflammatory drug (NSAID) and is approved by the Food and Drug Administration (FDA) for use following cataract surgery. Lotemax is made by Bausch & Lomb. It is a steroid and is also approved by the FDA for use following cataract surgery. |
| NCT00420628 ↗ | Pediatric Zylet Safety and Efficacy Study | Completed | Bausch & Lomb Incorporated | Phase 4 | 2006-11-01 | A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum) |
| NCT00447577 ↗ | Zylet vs TobraDex in Blepharokeratoconjunctivitis | Completed | Bausch & Lomb Incorporated | Phase 4 | 2007-01-01 | The objective of this study is to evaluate the safety and efficacy of Zylet vs. Tobradex in the treatment of ocular inflammation associated with blepharokeratoconjunctivitis |
| NCT00560638 ↗ | Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye | Completed | Bausch & Lomb Incorporated | Phase 2 | 2005-11-01 | This was a single-center, randomized, double-masked, placebo-controlled, parallel-group, 4-visit, CAE (Controlled Adverse Environment) study lasting approximately 4 weeks. Subjects were randomized to receive loteprednol etabonate ophthalmic suspension, 0.5% or placebo (vehicle of loteprednol etabonate ophthalmic suspension, 0.5%) and instructed to dose bilaterally either TID or QID according to randomization. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for loteprednol etabonate
Condition Name
Clinical Trial Locations for loteprednol etabonate
Trials by Country
Clinical Trial Progress for loteprednol etabonate
Clinical Trial Phase
Clinical Trial Sponsors for loteprednol etabonate
Sponsor Name
